SCHEMBL16265168

SCHEMBL16265168

c1csc(-c2ccc3nccn3n2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 2/20 0.54
▸ CLK4 Q9HAZ1 3/20 0.48
▸ KDR P35968 3/20 0.48
▸ JAK2 O60674 2/20 0.48
▸ RET P07949 2/20 0.48
▸ GSK3A P49840 2/20 0.48
▸ RPS6KA3 P51812 2/20 0.48
▸ LIMK1 P53667 2/20 0.48
▸ MAP2K1 Q02750 2/20 0.48
▸ ALK Q9UM73 2/20 0.48
▸ DYRK1B Q9Y463 2/20 0.48
▸ MAPK14 Q16539 2/20 0.48
▸ PRKCI P41743 1/20 0.43
▸ MAP4K4 O95819 2/20 0.43
▸ PRKACA P17612 2/20 0.43
▸ CDK8 P49336 2/20 0.43
▸ LRRK2 Q5S007 2/20 0.43
▸ AURKA O14965 1/20 0.43
▸ DAPK3 O43293 1/20 0.43
▸ ABL1 P00519 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2202066 0.75 APOBEC3A (0.47) DYRK1AKDRPDPK1RAB9AHSP90AA1
SCHEMBL360789 0.72 DYRK1A (0.77) DYRK1ACLK4KDRJAK2RET
SCHEMBL10201578 0.72 HSP90AA1 (0.44) PDPK1RAB9AHSP90AA1PDE10ALOXL2
SCHEMBL3514678 0.71 DYRK1A (0.70) DYRK1ACLK4KDRJAK2RET
SCHEMBL21643997 0.70 DYRK1A (1.00) DYRK1ACLK4KDRJAK2RET
Hydrochloric Acid SCHEMBL21411936 0.70 DYRK1A (0.68) DYRK1ACLK4KDRJAK2RET
SCHEMBL21412044 0.70 DYRK1A (0.54) DYRK1ACLK4KDRJAK2RET
SCHEMBL14881529 0.69 TGFBR1 (0.47) TGFBR1
Hydrochloric Acid SCHEMBL21411934 0.69 DYRK1A (0.53) DYRK1ACLK4KDRJAK2RET
SCHEMBL5487802 0.69 DYRK1A (0.52) DYRK1ACLK4KDRJAK2RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180186801-A1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2018-07-05 — — US disclosed
US-9957271-B2 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2018-05-01 — — US disclosed
US-20140349993-A1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2014-11-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140349993-A1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 DYRK1A 2222/4885CLK4 1839/4885KDR 1197/4885
US-20180186801-A1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 DYRK1A 2222/4885CLK4 1839/4885KDR 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback